Experienced in Low Sodium Level

Yasuhiro Takeshima

Kashihara-shi, JP 
Experienced in Low Sodium Level
Kashihara-shi, JP 
OverviewLocationsClinical Research

Overview

Yasuhiro Takeshima practices in Kashihara-shi, Japan. Mr. Takeshima is rated as an Experienced expert by MediFind in the treatment of Low Sodium Level. His top areas of expertise are Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Spinal Muscular Atrophy (SMA), Thrombectomy, and Spinal Fusion.

His clinical research consists of co-authoring 248 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Low Sodium Level.

Gender
Male

Locations

Kashihara-shi, 6348521, Japan
Other Locations
Nishinomiya-hama, Japan
Japan
Nara-shi, Japan
Kobe, 6508530, Japan
Hosei, Japan
Kashihara, Japan
Kyotanabe, Japan
Kyoto, Japan
Tokyo, Japan
Izumo, Japan
Fujieda, Japan
Fujimino, 3568533, Japan
Sendai, Japan
Tohoku, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3

248 Total Publications

Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.
Confirmatory long-term efficacy and safety results of ataluren in patients with nmDMD from Study 041, an international, randomized, double-blind, placebo-controlled, Phase III trial.
Journal: Journal of comparative effectiveness research
Published: August 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Takeshima's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 107 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile